Evidence map›Paper›PMID 38548828›Full record

Trial reportScientific reports2024

An effective COVID-19 vaccine hesitancy intervention focused on the relative risks of vaccination and infection.

Cameron O'Neill Byerley, Dru Horne, Mina Gong, Stacy Musgrave, Laura A Valaas, Brian Rickard, Hyunkyoung Yoon, Min Sook Park, Alison Mirin, Surani Joshua and 2 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Delay discounting predicts COVID-19 vaccine booster willingness.Cognitive research: principles and implications · 2025
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Cameron O'Neill ByerleyDepartment of Mathematics, Science, and Social Studies Education, University of Georgia, Athens, 30606, USA. cbyerley@uga.edu.
Dru HorneDepartment of Mathematics, Science, and Social Studies Education, University of Georgia, Athens, 30606, USA.
Mina GongDepartment of Mathematics, Science, and Social Studies Education, University of Georgia, Athens, 30606, USA.
Stacy MusgraveDepartment of Mathematics and Statistics, Cal Poly Pomona, Pomona, 91768, USA.
Laura A ValaasDepartment of Dermatology, University of Washington, Seattle, 98195, USA.
Brian RickardDepartment of Mathematical Sciences, University of Arkansas, Fayetteville, 72701, USA.
Hyunkyoung YoonDepartment of Mathematics and Statistics, Cal Poly Pomona, Pomona, 91768, USA.
Min Sook ParkDepartment of Information Studies, University of Wisconsin-Milwaukee, Milwaukee, 53201, USA.
Alison MirinDepartment of Mathematics, University of Arizona, Tucson, 85721, USA.
Surani JoshuaYavapai Elementary School, Scottsdale, 85257, USA.
Heather LavenderDepartment of Mathematics, Science, and Social Studies Education, University of Georgia, Athens, 30606, USA.
Sukjin YouDepartment of Information Studies, University of Wisconsin-Milwaukee, Milwaukee, 53201, USA.

Funding

National Science Foundation 2032688
6 · The paper itself

Abstract

We designed the Relative Risk Tool (RRT) to help people assess the relative risks associated with COVID-19 vaccination and infection. In May 2022 (N = 400) and November 2022 (N = 615), U.S. residents participated in a survey that included questions about the risks of vaccination and infection. In both cohorts, we found an association between relative risk perception and vaccine hesitancy. Participants in the May cohort were randomly assigned an intervention: to see information from the RRT or the Centers for Disease Control and Prevention (CDC). After the intervention, participants answered the same questions about risk perception and vaccination intent again. The RRT was more effective than the CDC at changing risk perception and increasing vaccination intent. In November, the survey structure was the same, but the RRT was the only intervention included, and we confirmed that the RRT was effective at changing opinions in this new sample. Importantly, the RRT provided accurate information about the risks of serious adverse outcomes to vaccination and still increased vaccination intent. Our work suggests that the RRT helps people assess relative risk, which can in turn help empower them to make informed decisions and ultimately reduce vaccine hesitancy.

Indexed as

COVID-19Centers for Disease Control and Prevention, U.S.COVID-19 VaccinesHumansIntentionRiskUnited StatesVaccinationCOVID-19 Vaccines

Identifiers

PMID38548828
PMCPMC10978892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.